Amgen plans $200M, 100-job add-on in Ireland; New UCB drugs almost offset Keppra sales drop;

 @FiercePharma: No hiving off units for incoming J&J chief Alex Gorsky. Instead: M&A in devices, emerging markets--Bloomberg. Story | Follow @FiercePharma

> Amgen ($AMGN) is plotting a $200 million, 100-job expansion in Ireland, with a new production plant, expanded warehouse, and R&D facilities. Article

> UCB's new products Cimzia, Neupro and Vimpat grew by 50% in the first quarter, helping to make up a 17% drop in sales of Keppra, which now faces generic competition. Report

> A Bayer unit sued Watson Pharmaceuticals ($WPI) for patent infringement, saying the genericsmaker aims to sell a copycat version of its erectile dysfunction drug Staxyn. Story

> India's Strides Arcolab plans to buy an FDA-approved manufacturing plant to speed its commercialization of new products. Report

> The Drug Enforcement Agency argued in court for the right to bar controlled substances from two CVS pharmacies in Florida linked to high volumes of oxycodone prescriptions. News

Biotech News

 @FierceBiotech: Txt msg reminders swell flu vaccine uptake--gr8! Item | Follow @FierceBiotech

 @JohnCFierce: The new CEO at AZ should get a 3-5 year shot at a turnaround in R&D. That leaves Lilly's Lechleiter in the hot seat on pipeline strategies. | Follow @JohnCFierce

 @RyanMFierce: Illumina to open app store for genomics, releases iPad app. Story | Follow @RyanMFierce

 @MarkHFierce: Australia is actively promoting a new R&D tax credit beneficial for biotech research and drug development. More | Follow @MarkHFierce

> Brennan's ouster at AstraZeneca sets stage for big changes in R&D. News

> Epizyme builds epigenetics lineup with $90M Celgene score. News

> Buzz: Is Bayer looking to buy Onyx Pharma? More

Medical Devices News

@FierceMedDev: EU Parliament takes action: PIP breast implants: "learn the lessons of this fraud." Release | Follow @FierceMedDev

> J&J's Gorsky will target device deals for emerging markets. Item

> Cadence lands more cash for device to improve walking ability. Article

Manufacturing News

> Fixing OTC production problems is a top priority for new J&J CEO. Story

> FDA, industry differ on level of track and trace needed in U.S. Article

> Amgen VP warns FDA about quashing manufacturing innovation of biosimilars. More

> Novartis remediation drags on longer than expected. Report

CRO News

> Tom Pike joins Quintiles as new CEO. Item

> INC Research to close another facility, laying off around 30. News

> Warnex repays debentures and sells analytical services division. Article

> Cetero and FDA reach resolution over the CRO's questionable reports. Story

Vaccines News

> Celebrating vaccines: World Immunization Week 2012. Commentary

> Nigeria commits to AIDS vaccine development. News

> 'Hypervirulent' salmonella could overwhelm a vaccine. More

> Shingles shot safe and well tolerated, study finds. Story

And Finally... Do pharma boards do their jobs? Report